Baji Petra
Baji Petra
E-mail megerősítve itt: uni-corvinus.hu
CímIdézteÉv
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
V Brodszky, P Baji, O Balogh, M Péntek
The European Journal of Health Economics 15 (1), 65-71, 2014
1072014
Biosimilars for the management of rheumatoid arthritis: economic considerations
L Gulácsi, V Brodszky, P Baji, HU Kim, SY Kim, YY Cho, M Péntek
Expert review of clinical immunology 11 (sup1), 43-52, 2015
572015
Informal payments for healthcare services and short‐term effects of the introduction of visit fee on these payments in Hungary
P Baji, M Pavlova, L Gulácsi, HC Zsófia, W Groot
The International journal of health planning and management 27 (1), 63-79, 2012
522012
A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia
V Brodszky, F Rencz, M Péntek, P Baji, PL Lakatos, L Gulácsi
Expert review of pharmacoeconomics & outcomes research 16 (1), 119-125, 2016
492016
User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders
P Baji, M Pavlova, LÓ Gulácsi, W Groot
Health Policy 102 (2-3), 255-262, 2011
492011
Alopecia areata and health‐related quality of life: a systematic review and meta‐analysis
F Rencz, L Gulácsi, M Péntek, N Wikonkál, P Baji, V Brodszky
British Journal of Dermatology 175 (3), 561-571, 2016
462016
Changes in equity in out-of-pocket payments during the period of health care reforms: evidence from Hungary
P Baji, M Pavlova, L Gulácsi, W Groot
International Journal for Equity in Health 11 (1), 36, 2012
442012
Hepatocellular carcinoma and the risk of occupational exposure
V Rapisarda, C Loreto, M Malaguarnera, A Ardiri, M Proiti, G Rigano, ...
World journal of hepatology 8 (13), 573, 2016
43*2016
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
P Baji, M Péntek, S Szántó, P Géher, L Gulácsi, O Balogh, V Brodszky
The European Journal of Health Economics 15 (1), 45-52, 2014
382014
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
P Baji, M PÚntek, L Czirjßk, Z Szekanecz, L Gulßcsi, V Brodszky
The European Journal of Health Economics 15 (1), 53-64, 2014
332014
EQ-5D in central and Eastern Europe: 2000–2015
F Rencz, L Gulácsi, M Drummond, D Golicki, VP Rupel, J Simon, EA Stolk, ...
Quality of Life Research 25 (11), 2693-2710, 2016
312016
Exploring consumers’ attitudes towards informal patient payments using the combined method of cluster and multinomial regression analysis-the case of Hungary
P Baji, M Pavlova, L Gulácsi, W Groot
BMC health services research 13 (1), 62, 2013
302013
Treatment preferences of originator versus biosimilar drugs in Crohn’s disease; discrete choice experiment among gastroenterologists
P Baji, L Gulácsi, BD Lovász, PA Golovics, V Brodszky, M Péntek, ...
Scandinavian journal of gastroenterology 51 (1), 22-27, 2016
282016
Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
O Balogh, V Brodszky, L Gulácsi, E Herédi, K Herszényi, H Jókai, ...
The European Journal of Health Economics 15 (1), 101-109, 2014
272014
The rituximab biosimilar CT-P10 in rheumatology and cancer: a budget impact analysis in 28 European countries
L Gulácsi, V Brodszky, P Baji, F Rencz, M Péntek
Advances in therapy 34 (5), 1128-1144, 2017
252017
Quality of life and costs in Parkinson's disease: a cross sectional study in Hungary
G Tamás, L Gulácsi, D Bereczki, P Baji, A Takáts, V Brodszky, M Péntek
PLoS One 9 (9), e107704, 2014
222014
Health promotion targeting older people
S Golinowska, W Groot, P Baji, M Pavlova
BMC health services research 16 (5), 345, 2016
212016
Health‐related quality of life and its determinants in pemphigus: a systematic review and meta‐analysis
F Rencz, L Gulácsi, B Tamási, S Kárpáti, M Péntek, P Baji, V Brodszky
British Journal of Dermatology 173 (4), 1076-1080, 2015
192015
Health status of the Hungarian population between 2000-2010
P Baji, V Brodszky, F Rencz, I Boncz, L Gulacsi, M Pentek
Orvosi hetilap 156 (50), 2035-2044, 2015
182015
Patients’ access to biological therapy in chronic inflammatory conditions; per capita GDP does not explain the intercountry differences
L Gulácsi, F Rencz, G Poór, Z Szekanecz, V Brodszky, P Baji, M Péntek
Annals of the rheumatic diseases 75 (5), 942-943, 2016
172016
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20